Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Fertilization01:24

In Vitro Fertilization

153
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
153
Oogenesis02:07

Oogenesis

63.1K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.1K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Meiosis II01:57

Meiosis II

181.5K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
181.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protective Role of Diatomite Against Freezing Stress in <i>Hordeum vulgare</i> L.: Insights into Physiological Mechanisms.

Biomolecules·2026
Same author

First molecular identification and characterization of Taenia lynciscapreoli in the Eurasian lynx (Lynx lynx) and Hydatigera taeniaeformis sensu stricto in domestic cats (Felis catus) from Central Asia.

Parasitology research·2026
Same author

Ophthalmological care delivery in East Kazakhstan: a qualitative study of ophthalmologists on system barriers and service organization.

Frontiers in public health·2026
Same author

Prevalence and Genetic Diversity of <i>Echinococcus granulosus</i> Sensu Stricto in Sheep from Kazakhstan.

Biology·2026
Same author

Determinants of HIV Testing Uptake Among People Who Use New Psychoactive Substances in Kazakhstan: A Multi-Regional Cross-Sectional Study.

Healthcare (Basel, Switzerland)·2026
Same author

Three decades of research on molecular genetic characteristics of Echinococcus spp.: a bibliometric study.

Folia parasitologica·2026

Related Experiment Video

Updated: May 12, 2025

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

4.5K

Assisted Reproductive Technologies and Oocyte Donation.

Leila Chalova1,2, Vyacheslav Lokshin3, Vladimir Kiyan4

  • 1LLP "M1" Health and Science Center, 010011, Astana, Kazakhstan.

Iranian Journal of Public Health
|May 7, 2025
PubMed
Summary

Assisted reproductive technologies (ART) face challenges with single-donor germ cells. Surveys reveal financial compensation drives oocyte donation, with experienced medical staff favoring donor tracking and limitations.

Keywords:
Assisted reproductive technologiesDonation motivesDonor rightsGamete donationOocyte donors

More Related Videos

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

5.8K
Analysis of Chromosome Segregation, Histone Acetylation, and Spindle Morphology in Horse Oocytes
12:11

Analysis of Chromosome Segregation, Histone Acetylation, and Spindle Morphology in Horse Oocytes

Published on: May 11, 2017

10.9K

Related Experiment Videos

Last Updated: May 12, 2025

Fertility Preservation in Patients with Severe Ovarian Dysfunction
12:03

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

4.5K
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

5.8K
Analysis of Chromosome Segregation, Histone Acetylation, and Spindle Morphology in Horse Oocytes
12:11

Analysis of Chromosome Segregation, Histone Acetylation, and Spindle Morphology in Horse Oocytes

Published on: May 11, 2017

10.9K

Area of Science:

  • Reproductive Medicine
  • Genetics
  • Sociology of Medicine

Background:

  • Unresolved issues persist in assisted reproductive technologies (ART) utilizing single-donor germ cells.
  • Assessing attitudes towards gamete donation in ART is crucial for addressing these challenges.

Purpose of the Study:

  • To evaluate the perspectives of medical professionals, oocyte recipients, and oocyte donors on gamete donation within ART.
  • To understand the social and ethical considerations surrounding donor gametes in fertility treatments.

Main Methods:

  • A survey was conducted with 286 participants across seven countries.
  • Participants included medical workers from ART clinics (n=190), oocyte recipients (n=45), and oocyte donors (n=51).

Main Results:

  • Financial compensation emerged as the primary motivator for oocyte donation, highlighting potential donor socioeconomic factors.
  • A significant majority of experienced medical workers (79.7%) advocated for regulated programs to track donor gametes and limit donor numbers.

Conclusions:

  • The study underscores the importance of establishing a unified registry for donor gametes.
  • Willingness among medical staff and oocyte recipients to utilize donor material and support a registry indicates a need for standardized practices in ART.